News
HOUSTON – Somnum Bene Holdings, the holding company of cpap.com, has appointed Joe Megibow as its new CEO.
Both CPAP and tirzepatide are acceptable treatments for comorbid obesity and OSA, with providers favoring CPAP and patients preferring tirzepatide.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback